Januvia is classed as a dipeptidyl peptidase-4 (DPP-4) inhibitor. Januvia does not cause side effects involving the genitals or urinary organs
JANUVIA contains the active ingredient sitagliptin. JANUVIA is a member of a class of medicines you take by mouth called DPP-4 inhibitors (dipeptidyl peptidase-
Januvia, or sitagliptin, is a medication that falls under the class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. Unlike Jardiance, Januvia works
Januvia is in the drug class dipeptidyl peptidase 4 inhibitors. Januvia is used to treat Diabetes, Type 2. Drug and food interactions. Moderate. SITagliptin
Examples. Drugs belonging to this class are: Sitagliptin (FDA approved 2024, marketed by Merck Co. as Januvia)
The lawsuits claim that type 2 diabetes drugs in the incretin class caused patients to develop pancreatic cancer. These drugs include Januvia
Dulaglutide (Trulicity) and semaglutide (Ozempic) are Drugs available in the United States from this class include sitagliptin (Januvia)
Both Januvia and Janumet belong to a class of drugs called dipeptidyl peptidase 4 (DPP-4) inhibitors that work by helping the body produce more insulin. Januvia
Farxiga is in the drug class SGLT-2 inhibitors. Farxiga is used to treat the following conditions: Chronic Kidney Disease; Diabetes, Type 2; Heart Failure; Januvia. A total of 287 drugs are known to interact with Januvia. Januvia is in the drug class dipeptidyl peptidase 4 inhibitors. Januvia is used to treat Diabetes, Type 2.
Antiviral drugs are a class of medication used specifically for treating viral infections